06 April 2022
Honeywell's Solstice N40 (R448A) refrigerant has been used for the first time in medical cold chain storage.
Sinopharm Shanghai Biomedical, a subsidiary of China National Pharmaceutical Group, has adopted Solstice N40 for cold storage of Sinopharm vaccines used in Shanghai, including the company’s COVID-19 vaccine.
"The storage and distribution of vaccines is an important task. We choose to partner with Honeywell to adopt its proven Solstice N40 solution, ensuring the medicine is stored safely and properly," said Baohua Zhang, chairman of Shanghai Xiongzhi Refrigeration Engineering, the general contractor of the vaccine cold storage project in Shanghai.
"As more Chinese refrigeration customers apply higher standards in terms of environmental protection and cost-effectiveness, we will continue cooperating with Sinopharm Shanghai Biomedical and other clients to fulfill social responsibility and achieve sustainable development."